KRISTEN LEBLANC: Open Payments
NPI 1538753926 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$445 in 24 payments from 15 companies in 2025. Trend: 2023 $122 · 2024 $428 · 2025 $445
Food & beverage: $445
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $81 |
| ABBVIE INC. | 2 | $67 |
| Novo Nordisk Inc | 3 | $57 |
| PFIZER INC. | 2 | $31 |
| Lilly USA, LLC | 2 | $29 |
| Davol Inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $20 |
| Ardelyx, Inc. | 1 | $19 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $18 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $18 |
Products named: UBRELVY, AIRSUPRA, Wegovy, Phasix Mesh, Dexcom G6 Transmitter, Ozempic, IBSRELA, JOURNAVX.
Industry payments across LA — which companies pay providers there.
